| Current Price | $89.84 | Mkt Cap | $199.8B |
|---|---|---|---|
| Open | $90.98 | P/E Ratio | 8.64 |
| Prev. Close | $89.84 | Div. (Yield) | $2.16 (2.3%) |
| Daily Range | $89.42 - $91.08 | Volume | 2,675,184 |
| 52-Wk Range | $74.09 - $94.26 | Avg. Daily Vol. | 1,900,837 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
| Current Price | $89.84 | Mkt Cap | $199.8B |
|---|---|---|---|
| Open | $90.98 | P/E Ratio | 8.64 |
| Prev. Close | $89.84 | Div. (Yield) | $2.16 (2.3%) |
| Daily Range | $89.42 - $91.08 | Volume | 2,675,184 |
| 52-Wk Range | $74.09 - $94.26 | Avg. Daily Vol. | 1,900,837 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
Recs
TMFjimhalley
(21.76)
Submitted: 3/10/2022 10:45:02 PM :
Start Price:
$83.25
NYSE:NVS Score:
+13.32
Under-priced stock with a strong portfolio and increased revenue.
Recs
TMFkodyk123
(70.61)
Submitted: 9/22/2021 4:16:06 PM :
Start Price:
$81.32
NYSE:NVS Score:
+18.40
Novartis has numerous fast-growing drugs, which is why analysts are expecting 8% annual earnings growth over the next five years. At just 13 times this year's earnings, Novartis is reasonably priced. That's why I expect the stock will outperform the S&P 500 in the next 5-10 years.
Find the members with the highest scoring picks in NVS.
wcwhiner (27.50) Score: +162.80
The Score Leader is the player with the highest score across all their picks in NVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Bankwatcher1 | 24.58 | 10/7/2008 |
|
NS | $37.26 | +140.98% | +293.05% | +152.07 | 0 Comment | |
| Spelunkin | 26.04 | 11/2/2009 |
|
5Y | $37.64 | +138.57% | +288.67% | +150.10 | 0 Comment | |
| PurePwnage | 92.81 | 11/27/2009 |
|
5Y | $39.92 | +124.93% | +273.36% | +148.43 | 0 Comment | |
| TrackDuality | < 20 | 11/6/2009 |
|
5Y | $38.04 | +136.02% | +280.88% | +144.86 | 0 Comment | |
| 39272x0 | 28.44 | 12/2/2009 |
|
5Y | $40.94 | +119.34% | +263.70% | +144.36 | 0 Comment | |
| kaChingkaChing | 34.96 | 12/2/2009 |
|
3W | $40.94 | +119.34% | +263.70% | +144.36 | 0 Comment | |
| wcwhiner | 27.50 | 4/28/2009 |
|
NS | $26.99 | +232.73% | +375.61% | +142.88 | 0 Comment | |
| DiamondDawg | 82.59 | 11/25/2009 |
|
5Y | $40.57 | +121.30% | +264.06% | +142.75 | 0 Comment | |
| 39272x4 | < 20 | 11/10/2009 |
|
5Y | $38.92 | +130.68% | +270.25% | +139.57 | 0 Comment | |
| BridgeTech | < 20 | 5/29/2009 |
|
3Y | $29.04 | +209.16% | +347.35% | +138.19 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
